Promotions & Moves
Related Searches:
Filter by:
October 9, 2007
Philip Vorwald has been appointed vice president and general manager of Celsis International's In Vitro Technologies (Celsis IVT) division. He will be responsible for setting and overseeing the long-term growth strategy of the company's ADME-Tox prod…
Read More »
October 8, 2007
Andrew Witty has been appointed chief executive officer designate, GlaxoSmithKline. Mr. Witty, currently president, Pharmaceuticals Europe for GSK, will succeed Dr. Jean-Pierre Garnier following his retirement as chief executive officer at the end of…
Read More »
October 8, 2007
Jay D. Norman has been appointed president of Quintiles Consulting business. The unit's offerings include strategic product development, regulatory compliance, and pricing and reimbursement. The company is investing in the growth of its consulting bu…
Read More »
October 5, 2007
Dr. Martin Mackay has been named president of Pfizer Global Research and Development (PGRD), an independent biotherapeutics and bioinnovation center under the direction of scientist Dr. Corey Goodman. Also, Dr. Briggs Morrison has been named head of…
Read More »
October 4, 2007
Hollings C. Renton, Onyx Pharmaceuticals' chief executive officer, announced plans to retire next year. Mr. Renton will remain chairman of the board of directors. The company has initiated a search for a successor. The company has promoted Laura A. B…
Read More »
October 3, 2007
Steve Jennings has been named senior vice president of sales, marketing and business development, AMRI. Mr. Jennings will be responsible for all of AMRI's global sales efforts, including sales teams in the U.S., Asia and Europe.
He has more tha…
Read More »
October 2, 2007
Eddie Montoya has been appointed director of IVRS, Bilcare Global Clinical Supplies. In his new role, Mr. Montoya will be responsible leading the expansion of IVRS/IWRS technology in the U.S. and globally for the benefit of Bilcare's clients.
Mr…
Read More »
September 28, 2007
Bernard Poussot has been appointed president and chief executive officer, Wyeth, effective January 1, 2008. He replaces Robert Essner, who will continue as chairman of the board of directors for the transition period.
Mr. Poussot joined the co…
Read More »
September 28, 2007
Patrick M. Sullivan has been named vice president of R&D for the Research Biotech business unit of Sigma-Aldrich. In this role, he will help expand the company's leadership position through the development of new and innovative products for life…
Read More »
September 21, 2007
DSM Pharmaceutical Products has made several management appointments. Mr. Leendert Staal, currently business group director DSM Pharmaceutical Products, will be appointed president of DSM Nutritional Products, reporting to Stephan Tanda, member of t…
Read More »
September 19, 2007
Robert J. Heine, M.D., Ph.D., F.R.C.P., will join Eli Lilly and Co. in January, 2008, as executive medical director for the diabetes and endocrine division responsible for development of Lilly's expanding diabetes and obesity R&D portfolio. Dr. H…
Read More »
September 13, 2007
Daniel G. Darazsdi has been appointed chief financial officer, PPD, Inc., effective October 1. Mr. Darazsdi joins the company after 25 years with Honeywell International, where he most recently served as vice president and chief financial officer of…
Read More »
September 12, 2007
Integrated Project Services (IPS) has appointed a new leadership team for its New Jersey operations. David J. Brown has been named regional office manager and will continue to lead the project services and project controls teams that support client p…
Read More »
September 6, 2007
Nancy J. Wysenski has been appointed chief operating officer, Endo Pharmaceuticals Inc., effective immediately. Ms. Wysenski will oversee the integration and execution of Endo's operating strategy, sourcing and commercializing its product portfolio,…
Read More »
September 5, 2007
Dr. Susan C. Stansfield has been appointed executive vice president, with responsibility for product registration activities in Europe, Africa and Asia-Pacific for PRA International. David Dockhorn, executive vice president, will continue to have res…
Read More »
